Vaginal mucoadhesive drug delivery systems

References

• Bachhav YG, Patravale VB. (2009). Microemulsion based vaginal gel of fluconazole: Formulation, in vitro and in vivo evaluation. Int J Pharm, 365:175–179.
   PubMed Web of Science ®Google Scholar
• Baloglu E, Senyigit ZA, Karavana SY, Bernkop-Schnürch A. (2009). Strategies to prolong the intravaginal residence time of drug delivery systems. J Pharm Pharm Sci, 12:312–336.
   PubMed Web of Science ®Google Scholar
• Hussain A, Ahsan F. (2005). The vagina as a route for systemic drug delivery. J Control Release, 103:301–313.
   PubMed Web of Science ®Google Scholar
• Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. (2011). Mucoadhesive drug delivery systems. J Pharm Bioallied Sci, 3:89–100.
   PubMed Web of Science ®Google Scholar
• Valenta C. (2005). The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev, 57:1692–1712.
   PubMed Web of Science ®Google Scholar
• Yoo JW, Dharmala K, Lee CH. (2006). The physicodynamic properties of mucoadhesive polymeric films developed as female controlled drug delivery system. Int J Pharm, 309:139–145.
   PubMed Web of Science ®Google Scholar
• Ndesendo VM, Pillay V, Choonara YE, du Toit LC, Buchmann E, Meyer LC et al. (2010). Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model. AAPS PharmSciTech, 11:793–808.
   PubMed Web of Science ®Google Scholar
• Pavelic Z, Skalko-Basnet N, Jalsenjak I. (2004). Liposomal gel with chloramphenicol: Characterisation and in vitro release. Acta Pharm, 54:319–330.
   PubMedGoogle Scholar
• Bhowmik BB, Nayak BS, Chatterjee A. (2009). Formulation development and characterization of metronidazole microencapsulated bioadhesive vaginal gel. Int J Pharm Pharmaceut Sci, 1:240–257.
   Google Scholar
• Albertini B, Passerini N, Di Sabatino M, Vitali B, Brigidi P, Rodriguez L. (2009). Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci, 36:591–601.
   PubMed Web of Science ®Google Scholar
• Bilensoy E, Rouf MA, Vural I, Sen M, Hincal AA. (2006). Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex. AAPS PharmSciTech, 7:38.
   PubMed Web of Science ®Google Scholar
• Ceschel GC, Maffei P, Lombardi Borgia S, Ronchi C, Rossi S. (2001). Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm, 27:541–547.
   PubMed Web of Science ®Google Scholar
• Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT et al. (2002). Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release, 82:39–50.
   PubMed Web of Science ®Google Scholar
• Francois M, Snoeckx E, Putteman P, Wouters F, De Proost E, Delaet U et al. (2003). A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole. AAPS PharmSci, 5:5.
   Google Scholar
• Gupta H, Sharma A. (2009). Ion activated bioadhesive in situ gel of clindamycin for vaginal application. Int J Drug Del, 1:32–40.
   Google Scholar
• Patel GM, Patel AP. (2010). A novel effervescent bioadhesive vaginal tablet of ketoconazole: Formulation band in vitro evaluation. Int J PharmTech Res, 2:656–667.
   Google Scholar
• Sharma G, Jain S, Tiwary AK, Kaur G. (2006). Once daily bioadhesive vaginal clotrimazole tablets: Design and evaluation. Acta Pharm, 56:337–345.
   PubMedGoogle Scholar
• Wang L, Tang X. (2008). A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: Design, in vitro and ‘in vivo’ evaluation. Int J Pharm, 350:181–187.
   PubMed Web of Science ®Google Scholar
• Dias A, Soares Sobrinho JL, Nunes LCC, La Roca MF, Cunha Filho MSS, Rolim Neto PJ. (2005). Sistema de liberação prolongada a partir de comprimidos matriciais bioadesivos vaginais contendo metronidazol. Rev Ciênc Farm Básica Apl, 26:217–220.
   Google Scholar
• Patel DB, Patel JK. (2009). Liposomal drug delivery of metronidazole for the local treatment of vaginitis. Int J Pharm Sci Nanotech, 2:421–427.
   Google Scholar
• Perioli L, Ambrogi V, Pagano C, Scuota S, Rossi C. (2009a). FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. Int J Pharm, 377:120–127.
   PubMed Web of Science ®Google Scholar
• Perioli L, Ambrogi V, Venezia L, Pagano C, Ricci M, Rossi C. (2008). Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels. Colloids Surf B Biointerfaces, 66:141–145.
   PubMed Web of Science ®Google Scholar
• Simoes JA, Bahamondes LG, Camargo RP, Alves VM, Zaneveld LJ, Waller DP et al. (2006). A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol, 61:211–217.
   PubMed Web of Science ®Google Scholar
• Acquarone M, Blasi N, Casella M, Ciangherotti F, Conforti M, Corradini E, Della Sala MR, Mannu L, Sbrignadello C, Senatori R, Stigliano CM. (2008). Efficacy and tolerability of a 0.25% chlorhexidine-based vaginal gel (Clomirex®) in non-pregnant women with bacterial vaginosis. Results of a multicenter, open-label trial. Eur Bull Drug Res, 16:1–4.
   Google Scholar
• Ahmad FJ, Alam MA, Khan ZI, Khar RK, Ali M. (2008). Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm, 58:407–419.
   PubMed Web of Science ®Google Scholar
• Alam MA, Ahmad FJ, Khan ZI, Khar RK, Ali M. (2007). Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections. AAPS PharmSciTech, 8:109.
   PubMed Web of Science ®Google Scholar
• Chopra S, Motwani SK, Iqbal Z, Talegaonkar S, Ahmad FJ, Khar RK. (2007). Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design. Eur J Pharm Biopharm, 67:120–131.
   PubMed Web of Science ®Google Scholar
• Garg S, Vermani K, Garg A, Anderson RA, Rencher WB, Zaneveld LJ. (2005). Development and characterization of bioadhesive vaginal films of sodium polystyrene sulfonate (PSS), a novel contraceptive antimicrobial agent. Pharm Res, 22:584–595.
   PubMed Web of Science ®Google Scholar
• Ramadan AA. (2008). Formulation and evaluation of bioadhesive gels containing miconazole nitrate. J App. Sci Res, 4:1052–1065.
   Google Scholar
• Bilensoy E, Çırpanlı Y, Şen M, Doğan L, Çalış S. (2007). Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: Cyclodextrin complex for HPV-induced cervical cancer. J Incl Phenom Macrocycl Chem, 57:363–370.
   Web of Science ®Google Scholar
• Bilensoy E, Moroy P, Çırpanlı Y, Bilensoy T, Çalış S, Mollamahmutoglu L. (2011). A double-blind placebo-controlled study of 5-fluorouracil: Cyclodextrin complex loaded thermosensitive gel for the treatment of HPV induced condyloma. J Incl Phenom Macrocycl Chem, 69:309–313.
   Web of Science ®Google Scholar
• Goodsell A, Zhou F, Gupta S, Singh M, Malyala P, Kazzaz J et al. (2008). β7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery. Immunology, 123:378–389.
   PubMed Web of Science ®Google Scholar
• Han IK, Kim YB, Kang HS, Sul D, Jung WW, Cho HJ et al. (2006). Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods, 38:106–111.
   PubMed Web of Science ®Google Scholar
• Perioli L, Ambrogi V, Pagano C, Massetti E, Rossi C. (2011). New solid mucoadhesive systems for benzydamine vaginal administration. Colloids Surf B Biointerfaces, 84:413–420.
   PubMed Web of Science ®Google Scholar
• Perioli L, Ambrogi V, Venezia L, Giovagnoli S, Pagano C, Rossi C. (2009b). Formulation studies of benzydamine mucoadhesive formulations for vaginal administration. Drug Dev Ind Pharm, 35:769–779.
   PubMed Web of Science ®Google Scholar
• Zaneveld LJ, Waller DP, Ahmad N, Quigg J, Kaminski J, Nikurs A et al. (2001). Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents. J Androl, 22:481–490.
   PubMed Web of Science ®Google Scholar
• Ahuja A, Khar RK, Ali J. (1997). Mucoadhesive drug delivery systems. Drug Dev Ind Pharm, 23:489–515.
   Web of Science ®Google Scholar
• Rohan LC, Sassi AB. (2009). Vaginal drug delivery systems for HIV prevention. AAPS Pharm Sci Tech, 11:78–87.
   Google Scholar
• Andrews GP, Laverty TP, Jones DS. (2009b). Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm, 71:505–518.
   PubMed Web of Science ®Google Scholar
• Duchêne D, Ponchel G. (1992). Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials, 13:709–714.
   PubMed Web of Science ®Google Scholar
• Carvalho FC, Bruschi ML, Evangelista RC, Gremião MPD. (2010). Mucoadhesive drug delivery systems. Braz J Pharm Sci, 46:1–18.
   Web of Science ®Google Scholar
• Lai SK, Wang YY, Hida K, Cone R, Hanes J. (2010). Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci USA, 107:598–603.
   PubMed Web of Science ®Google Scholar
• Bruschi ML, de Freitas O. (2005). Oral bioadhesive drug delivery systems. Drug Dev Ind Pharm, 31:293–310.
   PubMed Web of Science ®Google Scholar
• Bruschi ML, Jones DS, Panzeri H, Gremião MP, de Freitas O, Lara EH. (2007). Semisolid systems containing propolis for the treatment of periodontal disease: in vitro release kinetics, syringeability, rheological, textural, and mucoadhesive properties. J Pharm Sci, 96:2074–2089.
   PubMed Web of Science ®Google Scholar
• Farage M, Maibach H. (2006). Lifetime changes in the vulva and vagina. Arch Gynecol Obstet, 273:195–202.
   PubMedGoogle Scholar
• Boris S, Suárez JE, Vázquez F, Barbés C. (1998). Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun, 66:1985–1989.
   PubMed Web of Science ®Google Scholar
• Vásquez A, Jakobsson T, Ahrné S, Forsum U, Molin G. (2002). Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol, 40:2746–2749.
   PubMed Web of Science ®Google Scholar
• Dota KFD, Consolaro MEL, Svidzinski TIE, Bruschi ML. (2010). Antifungal activity of brazilian propolis microparticles against yeasts isolated from vulvovaginal candidiasis. eCAM Adv Access, 12:1–8.
   Google Scholar
• Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G et al. (2007). Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol, 73:5731–5741.
   PubMed Web of Science ®Google Scholar
• Bruschi ML. (2006). Desenvolvimento e caracterização de sistemas de liberação de própolis intrabolsa periodontal. Doctorate thesis, Pharmaceutical Sciences Faculty, São Paulo University, Ribeirão Preto, Brazil.
   Google Scholar
• Chidambaram N, Srivatsava AK. (1995). Buccal drug delivery systems. Drug Dev Ind Pharm, 21:1009–1036.
   Web of Science ®Google Scholar
• das Neves J, Amaral MH, Bahia MF. (2008). Performance of an in vitro mucoadhesion testing method for vaginal semisolids: Influence of different testing conditions and instrumental parameters. Eur J Pharm Biopharm, 69:622–632.
   PubMed Web of Science ®Google Scholar
• Álvares CA, Svidzinski TIE, Consolaro MEL. (2007). Candidíase vulvovaginal: Fatores predisponentes do hospedeiro e virulência das leveduras. J Bras Patol Med Lab, 43:319–327.
   Google Scholar
• Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. (2002). Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol, 99:419–425.
   PubMed Web of Science ®Google Scholar
• Ferrazza MHSH, Maluf MLF, Consolaro MEL, Shinobu CS, Svidzinski, TIE, Batista MR. (2005). Caracterização de leveduras isoladas da vagina e sua associação com candidíase vulvovaginal em duas cidades do sul do Brasil. Rev Bras Gin Obstet, 27:58–63.
   Google Scholar
• Harrison PF. (2000). Microbicides: Forging scientific and political alliances. AIDS Patient Care STDS, 14:199–205.
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. (2006). A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res, 23:2709–2728.
   PubMed Web of Science ®Google Scholar
• Jones DS, Bruschi ML, de Freitas O, Gremião MP, Lara EH, Andrews GP. (2009). Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. Int J Pharm, 372:49–58.
   PubMed Web of Science ®Google Scholar
• Valenta C, Kast CE, Harich I, Bernkop-Schnürch A. (2001). Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone. J Control Release, 77:323–332.
   PubMed Web of Science ®Google Scholar
• Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A. (2002). Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release, 81:347–354.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Giunchedi P, Scalia S, Rossi S, Sandri G, Caramella C. (2006). Chitosan gels for the vaginal delivery of lactic acid: Relevance of formulation parameters to mucoadhesion and release mechanisms. AAPS PharmSciTech, 7:104.
   PubMed Web of Science ®Google Scholar
• D’Cruz OJ, Samuel P, Uckun FM. (2005). Conceival, a novel noncontraceptive vaginal vehicle for lipophilic microbicides. AAPS PharmSciTech, 6:56–64.
   PubMedGoogle Scholar
• Curran RM, Donnelly L, Morrow RJ, Fraser C, Andrews G, Cranage M et al. (2009). Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses. Vaccine, 27:6791–6798.
   PubMed Web of Science ®Google Scholar
• El-Kamel A, Sokar M, Naggar V, Al Gamal S. (2002). Chitosan and sodium alginate-based bioadhesive vaginal tablets. AAPS PharmSci, 4:44.
   PubMedGoogle Scholar